VTRS acquires Aculys Pharma to boost its CNS portfolio in Japan, gaining rights to pitolisant and Spydia for narcolepsy and ...

The Centers for Disease Control and Prevention (CDC) estimates that 1.1% of US adults have epilepsy. Although 89% report seeing a physician in the past year about their condition, only 62% of adults ...

Doctors need reliable ways to predict seizure risk after a first unprovoked seizure, to help guide diagnosis and treatment. This is especially important because a diagnosis of epilepsy can now be made ...

EpiWatch, the Apple Watch-based epilepsy management company spun out from Johns Hopkins, announced it received FDA 510(k) clearance for its continuous seizure monitor platform that utilizes the ...

Vijayawada: Chief electoral officer Mukesh Kumar Meena directed district election officials to improve the use of the electronic seizure management system since the Election Commission of India will ...